Los puntos clave no están disponibles para este artículo en este momento.
Extracorporeal Photopheresis (ECP) may be considered the unique large-scale cell therapy currently available. It is currently employed mainly as second-line treatment, especially in steroid-resistant or steroid-dependent Graft versus Host Disease (GvHD) with good results and very few limitations.
Fante et al. (Tue,) studied this question.